BDMD

Baird Medical Investment Holdings Ltd. (BDMD) | Rumor.io

Baird Medical Investment Holdings

BDMD

Attention (50-day avg)0%

Attention rank (50-day avg)#4,180

Bullish sentiment (50-day avg)100%

Price to earnings ratio3.16

Market capitalization24.7M

Earnings per share-0.55

Dividend yield (TTM)—

Revenue (annual)22.5M

Net income (annual)-27.5M

Social

What share of all stock conversation is about BDMD?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% +0	0% +0	0% 0

Mar 23

The author believes BDMD is heading for a significant price drop, citing a potential reversal to $2.50+ if the major support zone at $1.15 is breached.
The author is suggesting a potential 100% price bounce, implying a significant increase in value.
The author is offering an exclusive bottom-fishing plan for BDMD, but no further details are provided.

Generated by AI

Sentiment

Of the messages about BDMD that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	100% 0	100% 0	83.28% +1.87
Bearish	0%	0% 0	0% 0	16.72% -1.87

Bullish· Mar 20

$BDMD's accelerated buyback program is gaining significant momentum, driving the stock up 25.88% and potentially leading to further gains.
The company's strategic expansion into new markets, including clinical workshops in Indonesia, is bolstering its market presence and contributing to the stock's surge.
$BDMD's share repurchase program is accelerating, signaling strong management confidence and potentially leading to a breakout on this bullish catalyst.

Bearish· Jan 17

The market is expecting a price drop to $12.45, with some investors already anticipating a backup.
The stock has a high cost to borrow, which could lead to a short squeeze on Monday.
The company's China ties may be a cause for concern, with some investors warning of a potential rug pull and 90% loss in value.

Generated by AI

Topics

Of the messages about BDMD that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	53.23%
Analysts	—	—	0%	0%
Controversies	—	—	0%	0%
Earnings	—	—	0%	0.54%
Macro	—	—	0%	0.54%
Technical Analysis	—	—	0%	45.7%

Announcements· Mar 20

*BDMD surges to $2.11, up 24.12%, driven by clearing regulatory overhang and expansion of clinical education in Indonesia.*
*BDMD surges to $2.14, up 25.88%, driven by accelerated share repurchase program and strategic expansion of clinical workshops in Indonesia.*
*BDMD decisively breaks $1.86 resistance on 2.94M volume, confirming powerful momentum ignition driven by clinical education expansion in Indonesia.*

Technical Analysis· Mar 20

$BDMD has decisively breached the $1.87 resistance on high volume, confirming a high-momentum technical breakout.
The price action has resulted in a +25.88% surge, with a technical target of $2.85, driven by institutional momentum and news-driven catalysts.
The breakout has been confirmed by massive volume, with a target of $2.98 following the +28.82% surge, underpinned by news-driven catalysts such as clinical education expansion.

Generated by AI

Community

Of the messages about BDMD, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	80%	55.56%	12.56%
Newcomers	0%	20%	44.44%	87.44%

Mar 23

The newcomer is concerned about the asset's potential to reach a major support zone, which could lead to a significant price drop.
The newcomer is suggesting a potential 100% reversal bounce to a price of $2.50 or higher.
The newcomer is offering a "bottom-fishing plan" for those interested in investing in the asset despite its current downward trend.

Generated by AI

NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Limited (“Baird Medical” or the “Company”) (Nasdaq: BDMD), a global medical technology company focused on the development and commercialization of minimally invasive treatment solutions, today announced that management will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York City. H.C. Wainwright 28th Annual Global Investment ConferenceDate: Wednesday, September 16, 2026Time: 11:30 a.m.

15d agoYahoo Finance

12 Health Care Stocks Moving In Monday's After-Market Session

15d agoBenzinga

Baird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation Technology

COPENHAGEN, Denmark, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (“Baird Medical” or the “Company”) (Nasdaq: BDMD)...

15d agomarkets.businessinsider.com

BDMD: Baird Medical Reports Strong Revenue Growth for the 6-Month Period Ending 6/30/26

By Tom Kerr, CFA NASDAQ: BDMD READ THE FULL BDMD RESEARCH REPORT Interim Financial Results On September 3, 2026, Baird Medical (NASDAQ: BDMD) released financial results for the 6-month period ending June 30, 2026, which showed strong revenue growth from non-China regions. Revenue grew 24.6% to approximately $9.9 million in the 1st half of 2026, compared with $8.0 million in the prior-year period.

20d agoYahoo Finance

Baird Medical reports 24.6% revenue growth in first half

26d agoInvesting.com

Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026

Revenue increase driven by significant growth in the United States and other strategic marketsNEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”), today announced preliminary unaudited financial results for the six months ended June 30, 2026. Revenue for the first half of 2026 was approximately $9.9 million, an increase of 24.6% over $8.0 million reported for the six months ended June 30, 2025. The increase in reve

27d agoYahoo Finance

Also Discussed

Investors talking about BDMD also mention

#	Name	Attention
1	MKDWELL Tech Inc.MKDW	0%+0
2	LiveWire Group, Inc.LVWR	0%new
3	Neo-Concept International Group Holdings Limited Class A Ordinary SharesNCI	0.01%+0.01
4	LanzaTech Global Inc. Common StockLNZA	0%new
5	VinFast Auto Ltd. WarrantVFSWW	0%0
6	Fidelity Disruptive Technology ETFFDTX	0%0
7	Avanos Medical Inc.AVNS	0%0
8	Distribution Solutions Group, Inc.DSGR	0%0
9	Collplant Biotechnologies LtdCLGN	0%0
10	Falcon's Beyond Global, Inc. Class A Common StockFBYD	0%new

Baird Medical Investment Holdings Ltd.

Healthcare
Medical Devices

Baird Medical Investment Holdings Ltd. is a medical technology company focused on the research, development, manufacturing, and sale of microwave ablation devices and related medical products. Its portfolio includes microwave ablation apparatus and needles used in minimally invasive treatment of benign and malignant tumors, such as thyroid nodules, liver cancer, lung cancer, breast lumps, and uterine fibroids. The company also develops devices for soft tissue ablation, serving healthcare providers that perform image-guided and minimally invasive procedures. Baird Medical Investment Holdings Ltd. operates in the medical devices sector, where microwave ablation technology plays a specialized role in interventional oncology and other therapeutic applications. Headquartered in Guangzhou, China, the company is positioned around clinically targeted device innovation and distribution for hospital and physician use.

Website

Location

Baide Building, Building 11

Guangzhou, 510000

China

Social

What share of all stock conversation is about BDMD?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% +0	0% +0	0% 0

Mar 23

The author believes BDMD is heading for a significant price drop, citing a potential reversal to $2.50+ if the major support zone at $1.15 is breached.
The author is suggesting a potential 100% price bounce, implying a significant increase in value.
The author is offering an exclusive bottom-fishing plan for BDMD, but no further details are provided.

Generated by AI

Sentiment

Of the messages about BDMD that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	100%	100% 0	100% 0	83.28% +1.87
Bearish	0%	0% 0	0% 0	16.72% -1.87

Bullish· Mar 20

$BDMD's accelerated buyback program is gaining significant momentum, driving the stock up 25.88% and potentially leading to further gains.
The company's strategic expansion into new markets, including clinical workshops in Indonesia, is bolstering its market presence and contributing to the stock's surge.
$BDMD's share repurchase program is accelerating, signaling strong management confidence and potentially leading to a breakout on this bullish catalyst.

Bearish· Jan 17

The market is expecting a price drop to $12.45, with some investors already anticipating a backup.
The stock has a high cost to borrow, which could lead to a short squeeze on Monday.
The company's China ties may be a cause for concern, with some investors warning of a potential rug pull and 90% loss in value.

Generated by AI

Topics

Of the messages about BDMD that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	53.23%
Analysts	—	—	0%	0%
Controversies	—	—	0%	0%
Earnings	—	—	0%	0.54%
Macro	—	—	0%	0.54%
Technical Analysis	—	—	0%	45.7%

Announcements· Mar 20

*BDMD surges to $2.11, up 24.12%, driven by clearing regulatory overhang and expansion of clinical education in Indonesia.*
*BDMD surges to $2.14, up 25.88%, driven by accelerated share repurchase program and strategic expansion of clinical workshops in Indonesia.*
*BDMD decisively breaks $1.86 resistance on 2.94M volume, confirming powerful momentum ignition driven by clinical education expansion in Indonesia.*

Technical Analysis· Mar 20

$BDMD has decisively breached the $1.87 resistance on high volume, confirming a high-momentum technical breakout.
The price action has resulted in a +25.88% surge, with a technical target of $2.85, driven by institutional momentum and news-driven catalysts.
The breakout has been confirmed by massive volume, with a target of $2.98 following the +28.82% surge, underpinned by news-driven catalysts such as clinical education expansion.

Generated by AI

Community

Of the messages about BDMD, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	80%	55.56%	12.56%
Newcomers	0%	20%	44.44%	87.44%

Mar 23

The newcomer is concerned about the asset's potential to reach a major support zone, which could lead to a significant price drop.
The newcomer is suggesting a potential 100% reversal bounce to a price of $2.50 or higher.
The newcomer is offering a "bottom-fishing plan" for those interested in investing in the asset despite its current downward trend.

Generated by AI

Baird Medical Investment Holdings

Social

Mar 23

Sentiment

Bullish· Mar 20

Bearish· Jan 17

Topics

Announcements· Mar 20

Technical Analysis· Mar 20

Community

Mar 23

News

Baird Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference

12 Health Care Stocks Moving In Monday's After-Market Session

Baird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation Technology

BDMD: Baird Medical Reports Strong Revenue Growth for the 6-Month Period Ending 6/30/26

Baird Medical reports 24.6% revenue growth in first half

Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026

Also Discussed

Baird Medical Investment Holdings Ltd.

Company Information

Location

News

Baird Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference

12 Health Care Stocks Moving In Monday's After-Market Session

Baird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation Technology

BDMD: Baird Medical Reports Strong Revenue Growth for the 6-Month Period Ending 6/30/26

Baird Medical reports 24.6% revenue growth in first half

Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026

Also Discussed

Social

Mar 23

Sentiment

Bullish· Mar 20

Bearish· Jan 17

Topics

Announcements· Mar 20

Technical Analysis· Mar 20

Community

Mar 23